Literature DB >> 18764910

Autologous peripheral blood stem-cell transplantation with a double-conditioning regimen for recurrent hepatoblastoma after liver transplantation--a valid therapeutic option or just too much?

Giorgio Perilongo, Jean Bernard Otte.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18764910     DOI: 10.1111/j.1399-3046.2008.01015.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


× No keyword cloud information.
  5 in total

Review 1.  Current and future management strategies for relapsed or progressive hepatoblastoma.

Authors:  Rajkumar Venkatramani; Wayne L Furman; Joerg Fuchs; Steven W Warmann; Marcio H Malogolowkin
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

2.  Several important in vitro improvements in the amplification, differentiation and tracing of fetal liver stem/progenitor cells.

Authors:  Wei-hui Liu; Zheng-cai Liu; Nan You; Ning Zhang; Tao Wang; Zhen-bin Gong; Hong-bao Liu; Ke-feng Dou
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

Review 3.  Unresectable hepatoblastoma: current perspectives.

Authors:  Angela D Trobaugh-Lotrario; Rebecka L Meyers; Allison F O'Neill; James H Feusner
Journal:  Hepat Med       Date:  2017-02-01

Review 4.  How Do Synchronous Lung Metastases Influence the Surgical Management of Children with Hepatoblastoma? An Update and Systematic Review of the Literature.

Authors:  Roberta Angelico; Chiara Grimaldi; Carlo Gazia; Maria Cristina Saffioti; Tommaso Maria Manzia; Aurora Castellano; Marco Spada
Journal:  Cancers (Basel)       Date:  2019-10-31       Impact factor: 6.639

5.  Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma.

Authors:  Sorin Armeanu-Ebinger; Alexander Hoh; Julia Wenz; Joerg Fuchs
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.